<DOC>
	<DOCNO>NCT01734902</DOCNO>
	<brief_summary>The objective current trial establish bioequivalence 2 hyoscine butylbromide dose form follow oral administration .</brief_summary>
	<brief_title>Relative Bioavailability Study Investigate Compare Two Different Formulations Hyoscine Butylbromide Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male female subject Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>